NASDAQ · Biotechnology

Fortrea Holdings Inc. (FTRE) Stock

$20.37 -0.92% NASDAQ: FTRE Healthcare

Valuation

MetricValue
Price$20.37
Market Cap$1.94B
P/E Ratio-21.51
P/B Ratio3.60
P/S Ratio0.71
EPS (TTM)$-10.81
52-Week High$22.78
52-Week Low$8.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.53%
ROA-3.14%
ROCE0.63%
Gross Margin-1.14%
Operating Margin-1.14%
Net Margin-3.18%
Debt/Equity2.13
Current Ratio0.98

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.1B$2.8B$2.8B$2.7B$2.7B
Operating Profit$114.0M$187.0M$32.0M$-162.0M$-31.0M
Net Profit$98.0M$186.0M$-25.0M$-328.0M$-986.0M
EPS$1.11$2.11$-0.04$-3.67$-10.81
Op Margin3.7%6.6%1.1%-6.0%-1.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$4.4B$4.3B$4.3B$3.6B$2.7B
Total Liabilities$1.1B$945.0M$2.6B$2.2B$2.2B
Cash$95.0M$112.0M$109.0M$119.0M$175.0M
Borrowings$77.0M$63.0M$1.7B$1.2B$1.1B

Latest News

FTRE: Raising target price to $19.00 Argus Research · Jul 15, 2026 BofA Adjusts Price Target on Fortrea Holdings to $11 From $9.50 MT Newswires · Jul 13, 2026 Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call GlobeNewswire · Jul 13, 2026 Fortrea (FTRE) Stock Still Screens Cheap After Its 248% Run Simply Wall St. · Jul 12, 2026 Is Fortrea Holdings (FTRE) Overvalued After Its Rally To $17.76? Simply Wall St. · Jul 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$170.0M$83.0M$168.0M$263.0M$114.0M
Investing Cash Flow$-53.0M$-108.0M$-72.0M$226.0M$-11.0M
Financing Cash Flow$-128.0M$-6.0M$-1.8B$-15.0M$0
Net Cash Flow$14.0M$16.0M$-2.0M$10.0M$56.0M
Free Cash Flow$143.0M$28.0M$128.0M$237.0M$88.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.11
EV / EBITDA35.11
FCF Yield7.92%
Quick Ratio0.96
Interest Coverage0.13
Return 1Y206.66%
Return 3Y-42.73%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CERTCertara, Inc. $8.64 -3.57% -21.11 $1.34B 0.00%
MEDPMedpace Holdings, Inc. $602.70 -0.26% 35.86 $16.82B 0.00%

About Fortrea Holdings Inc.

Fortrea Holdings Inc. is led by CEO Anshul Thakral, employs 15,000 people, headquartered in US, publicly traded since 2023.

Fortrea Holdings Inc. (FTRE) stock trades at $20.37 with a market capitalization of $1.94B. The stock is valued at a price-to-earnings (P/E) ratio of -21.51, price-to-book of 3.60, price-to-sales of 0.71. Over the past 52 weeks the stock has ranged between $8.55 and $22.78, and currently trades 10.6% below its 52-week high.

On profitability, Fortrea Holdings Inc. generates a return on equity (ROE) of -15.53%, return on capital employed of 0.63%, an operating margin of -1.14%, a net profit margin of -3.18%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides